CHMMF Financials
Chimeric Therapeutics Limited - Financial statements & key metrics
Stock Price
$0.00
Market Cap
$4.42M
EPS
$-0.01
Income Statement Highlights
Most Recent Quarter: 2025-06-30
Revenue
$3.97M
Gross Profit
$3.12M
Operating Income
$-15.11M
Net Income
$-10.43M
EPS (Diluted)
$-
Balance Sheet Highlights
Total Assets
$21.57M
Total Liabilities
$19.60M
Shareholders Equity
$1.97M
Cash & Equivalents
$5.76M
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$-7.28M
CapEx
$0
Free Cash Flow
$-7.28M
Profitability Metrics
Gross Margin
91.3%
Operating Margin
-0.5%
Net Margin
-1.9%
ROE
-12.9%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is CHMMF revenue?
CHMMF's most recent quarterly revenue was $3.97M. Annual revenue can be calculated by summing the four most recent quarters.
Is CHMMF profitable?
CHMMF reported a loss of $10.43M in the most recent quarter. The net profit margin is -1.9%.
What is CHMMF market cap?
CHMMF has a market capitalization of $4.42M, making it a small-cap stock.
Does CHMMF have debt?
View CHMMF's balance sheet for debt information.
What is CHMMF cash flow?
CHMMF's most recent quarterly free cash flow was $-7.28M.